Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
2019 ASH Review on MCL: Can Anti-CD19 CAR-T Cell Therapy Be Used for Mantle Cell Lymphoma Patients After BTK Inhibitor Failure?
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Brian Hill
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Brian Hill
Comments 0
Login to view comments.
Click here to Login
